New Zealand’s Fonterra and Abbott, the US big pharma and health care giant are to develop a dairy farm hub in China.
The deal, subject to regulatory approval will see the two companies form a joint venture to invest a combined €220m ($300m).
The hub will contain up to five dairy farms and more than 16,000 cows, which will produce up to 160m litres of milk annually.
The herd will be made up with animals either imported, or sourced from Fonterra’s existing farm hubs.
The first farm is expected to be completed and producing milk in the first half of 2017 and the remaining farms will commence production in 2018.
All dairy cows will have genetics traceable to New Zealand, Australia, USA or Europe.
For further deal information visit Current Agreements (subscription required)
Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary
Report: Practical Guide to Finding Partners
Report: Partnering Deals and Alliances with Bayer
Report: Bigpharma Partnering Yearbook 2013
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity